Walter Stüdeli (Managing Director SVKH) comments in OTX-World No. 177 of June 2015 on the 2nd ordinary revision of the Therapeutic Products Act in Parliament and Swissmedic’s authorization practice. OTX_World_117_2015_Stuedeli (PDF)
Walter Stüdeli (Managing Director SVKH) comments in OTX-World No. 177 of June 2015 on the 2nd ordinary revision of the Therapeutic Products Act in Parliament and Swissmedic’s authorization practice. OTX_World_117_2015_Stuedeli (PDF)